Knowledge and adherence to antihypertensive therapy in primary care: Results of a randomized trial;Conocimiento y adherencia a la terapia antihipertensiva en atención primaria: resultados de un ensayo clínico

Gaceta Sanitaria

Volumn 25, Issue 1, 2011, Pages 62-67

  Amado Guirado, Ester ^a   Pujol Ribera, Enriqueta ^a   Pacheco Huergo, Valeria ^a   Borras, Josep M ^b  

^a Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adherence; Health education; Hypertension; Knowledge; Therapy

Indexed keywords

EID: 79952237943     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2010.09.015     Document Type: Article

References (35)

1. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998, 351:1755-1762.
2. Van den Hoogen P.C., Feskens E.J., Nagelkerke N.J., et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. NEJM 2000, 342:1-8.
3. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood. JAMA. 2003, 289:2560-2572.
4. Mazzaglia G., Ambrosioni E., Alacqua M., et al. Adherence to antihipertensive medications and cardiovascular morbidity among newly diagnosed hipertensive patients. Circulation. 2009, 120:1598-1605.
5. Chobanian A.V. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med. 2009, 361:878-887.
6. Adherence to long-term therapies: evidence for action. Geneve: WHO; 2003.
7. DiMatteo R. Variations in patients' adherence to medical recommendation: a quantitative review. Med Care. 2004, 42:200-209.
8. Horwitz R., Viscoli C.M., Berkman L., et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990, 336:542-545.
9. Miller N.H., Kottke T., Ockene I.S. The multilevel compliance challenge: recommendations and a call for action. Circulation. 1997, 95:1085-1090. for the expert panel on compliance.
10. Benson J., Britten N. Patients decision about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002, 325:1-5.
11. Newell S., Bowman J., Cockburn J.D. A critical review of interventions to increase adherence to medication-taking, obtaining medication refills and appointment-keeping in the treatment of cardiovascular disease. Prev Med. 1999, 29:535-548.
12. Roter D.L., Hall J.A., Menisca R., et al. Effectiveness of interventions to improve compliance: a meta-analysis. Med Care. 1998, 36:1138-1161.
13. Haynes R.B., Yao X., Degani A., et al. Interventions to enhance medication adherence. Cochrane Database Syst Review. 2005, (Issue 4). Art CD000011.
14. McDonald H., Garg A., Haynes B. Interventions to enhance patients' adherence to medication prescriptions. JAMA. 2002, 288:2868-2879.
15. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence. Its importance in cardiovascular outcomes. Circulation. 2009, 119:3028-3035.
16. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med. 2005, 353:487-497.
17. Puigventós F., Llodrà V., Vilanova M., et al. Cumplimiento terapéutico en el tratamiento de la hipertensión: 10 años de publicaciones en España. Med Clin (Barc) 1997, 109:702-706.
18. Gil V.F., Belda J., Piñeiro F., et al. Incumplimiento de la terapéutica farmacológica en la hipertensión arterial. Med Clin (Barc). 2001, 116(Suppl 2):29-37.
19. Amado Guirado E., Brotons Cuixart C., Dalfó Baqué A., et al. Hipertensió arterial 2003, Institut Català de la Salut, Barcelona.
20. Bonet Monné S., Casals Font A., Cots Yago J.M., et al. Patologia infecciosa del tracte respiratori baix 2006, Institut Català de la Salut, Barcelona.
21. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index including Defined Daily Doses (DDDs) for Plain Substances. Available at: http://www.whocc.no/atcddd/.
22. Batalla C., Blanquer A., Ciurana R., et al. Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Aten Primaria. 1984, 1:185-191.
23. Morisky D.E., Green L.E., Levine A.M. Concurrent and predictor validity of self-reported measure of medication adherence. Med Care. 1986, 1:67-74.
24. Val A., Amorós G., Martínez P., et al. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky-Green. Aten Primaria. 1992, 10:767-770.
25. Mar J., Rodríguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?. J Hypertens. 2001, 19:149-155.
26. Cook N.R., Cohen J., Hebert P.R., et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995, 155:701-709.
27. Sans S., Paluzie G., Balañà Ll, et al. Tendencias de la prevalencia, conocimiento, tratamiento y control de la hipertensión arterial entre 1986 y 1996, Estudio MONICA-Catalunya. Med Clin (Barc). 2001, 117:246-253.
28. Takiya L.N., Peterson A.M., Finley R.S. Meta-analysis of interventions for medication adherence to antihypertensives. Ann Pharmacother. 2004, 38:1617-1624.
29. Schoerder K., Fahey T., Ebrahim S. How can we improve adherence to blood pressure lowering medication in ambulatory care? Arch Intern Med. 2004, 164:722-732.
30. Kripalami S., Yao X., Haynes R.B. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med. 2007, 167:540-550.
31. Brotons C., Ciurana R., Pineiro P., et al. Dietary advice in clinical practice: the views of general practitioner. Am J Clin Nutr. 2003, 77(Suppl):S1048-S1051.
32. Bosworth H.B., Olsen M.K., Gentry P., et al. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Pat Educ Counsel. 2005, 57:5-14.
33. Green L., Lewis F.M. Measurement and evaluation in health education and health promotion 1986, Mayfield, Palo Alto.
34. Wang P.S., Benner J.S., Glynn R.J., et al. How well do patients report on non compliance with hypertensive medication? A comparison of self-report versus filled prescriptions. Pharmaco-Epidemiol Drug Safety. 2004, 13:11-19.
35. Garber M., Nau D., Erikson S.R., et al. The concordance of self-report with other measures of medication adherence. Med Care. 2004, 42:649-652.